26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Not surprisingly, OTO, LLC, the employer in OTO, L.L.C. v. Kho, 8 Cal. 5th 111 (2019), on January 13...
Read More >
CSG Labor & Employment Alert - The U.S. Department of Labor’s Occupational Safety and Health Admin...
Read More >
Depending on whom you ask, labor law during the Obama administration was “the best of times, the wo...
Read More >
This week the General Assembly of North Carolina provided some relief to developers with active deve...
Read More >
Companies who use app-based technology platforms to connect consumers directly with service provider...
Read More >
On August 20, 2019, the Ninth Circuit dodged answering the question of whether morbid obesity is a d...
Read More >